semaglutide fda news 🎉Exciting that is now approved for MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Wegovy® Lawsuit | July 2026

The British Association of Dermatologists is now on the alert for patients with warning signs of unusual orange tans and disordered moles

Temperature and humidity in your injection environment influence medication handling, tissue characteristics, and healing responses

Treatment of acute mountain sickness by simulated descent: a randomised controlled trial

Research Dosing Protocols Clinical trial dosing provides the foundation for understanding Retatrutide response patterns

(Official manufacturer guidelines on mechanism of action, contraindications, and adverse reactions)

Looking for support with medicines optimisation